生物技術中的人工智慧市場：按組件、按應用、按最終用戶、按地區

預計2024年全球人工智慧在生物技術市場的規模將達到21億美元，預計到2031年將達到71.1億美元，2024年至2031年的複合年成長率為19%。

圖：2024 年人工智慧在生物技術領域的市場佔有率（%），按地區分類

由於人工智慧和機器學習等各個領域的技術發展，生物技術領域正在快速發展。生物技術領域擴大在從藥物發現和基因組分析到臨床試驗監測和精準醫療的各個領域利用人工智慧。人工智慧工具正在幫助研究人員處理大量基因組和資料，資料獲得對疾病機制的新見解。深度學習、神經網路和自然語言處理等多種人工智慧驅動的技術可以透過支援標靶識別、先導藥物最適化、毒性預測和生物標記發現等關鍵功能來顯著加速藥物開發過程。人工智慧可以幫助生物技術公司更有效地監控和管理臨床試驗。它還有望應用於個人化醫療，支持根據每位患者的遺傳特徵和病歷客製化的治療提案。全球人工智慧在生物技術市場的成長是由這些技術在製藥/生物技術產業和醫療保健中越來越多的採用所推動的。

市場動態：

全球人工智慧在生物技術市場的成長是由人工智慧新興企業的資金增加所推動的，這些新創公司開發醫療保健和生命科學解決方案、需要高級分析和患者生成的複雜生物資料，這是由新興市場擴張等資料推動的。然而，缺乏熟練勞動力、資料品質問題以及與人工智慧和巨量資料相關的安全和監管問題等因素可能會阻礙其採用。預測分析、機器學習和人工智慧在精準醫學、個人化治療、基因治療和診斷中的擴展應用可以為市場成長提供機會。

本研究的主要特點

• 本報告對全球生物技術領域的人工智慧市場進行了詳細分析，並給出了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
• 它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
• 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球生物技術市場人工智慧的主要企業。
• 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 生物技術人工智慧全球市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。

目錄

第1章 研究目的與前提

• 研究目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• 一致的機會地圖 (COM)

第3章市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球人工智慧在生物技術市場中－冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章 2019-2031 年生物技術領域的人工智慧市場（按組成部分）（十億美元）

• 介紹
• 軟體
• 硬體
• 服務

第6章 2019-2031 年生物技術領域的人工智慧市場（按應用分類）（十億美元）

• 介紹
• 藥物發現與開發
• 臨床試驗和最佳化
• 醫學影像
• 診斷
• 其他

第 7 章 生物技術領域的人工智慧市場，按最終用戶分類，2019-2031 年（十億美元）

• 介紹
• 製藥公司
• 生技公司
• 學術研究所
• 醫療提供者
• CRO 和 CDMO
• 其他

第8章 生物技術市場中的人工智慧，按地區分類，2019-2031（十億美元）

• 介紹
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東

第9章 競爭格局

• 公司簡介
  • AstraZeneca
  • Bristol-Myers Squibb
  • Gilead Sciences, Inc.
  • Sanofi
  • Abbott Laboratories
  • Biogen
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Amgen, Inc.
  • Merck KGaA
  • Johnson &Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Deep Genomics
  • NVIDIA Corporation
  • Verge Genomics
  • Recursion Pharmaceuticals

第10章分析師建議

• 上升和下降
• 綜合機會圖

第11章 參考文獻與調查方法

• 參考
• 調查方法

Global AI in biotechnology market is estimated to be valued at USD 2.10 Bn in 2024 and is expected to reach USD 7.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 19% from 2024 to 2031.

Figure. Artificial Intelligence (AI) in Biotechnology Market Share (%), By Region 2024

The field of biotechnology has witnessed rapid advancements due to technological developments in various domains including artificial intelligence and machine learning. AI is being increasingly used in biotechnology for applications ranging from drug discovery and genome analysis to clinical trial monitoring and precision medicine. AI tools help researchers to process huge volumes of genomic and proteomic data and gain novel insights into disease mechanisms. Several AI-powered techniques like deep learning, neural networks, natural language processing, and others assist in critical functions like target identification, lead optimization, toxicity prediction and biomarker discovery, thus, significantly accelerating the drug development process. AI help biotech companies in monitoring and managing clinical trials more efficiently. It also has promising applications in personalized medicine by supporting treatment recommendations tailored to individual patients' genetic profile and medical history. Global AI in biotechnology market growth is driven by rising adoption of these technologies in pharma/biotech industry and healthcare.

Market Dynamic:

Global AI in biotechnology market growth is driven by factors like increasing funding for AI startups developing solutions for healthcare and life sciences, growing volumes of complex biological and patient-generated healthcare data requiring sophisticated analysis, and rising need to enhance R&D productivity and reduce costs in drug discovery. However, factors like lack of skilled workforce, data quality issues, security and regulatory concerns related to AI and big data can hamper its adoption. Expanding applications of predictive analytics, machine learning and artificial intelligence in precision medicine, personalized therapeutics, gene therapies and diagnostics can offer market growth opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global AI in biotechnology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global AI in biotechnology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Intel Corporation, NVIDIA Corporation, IBM Corporation, Microsoft Corporation, Amazon Web Services, Anthropic, Berg Health, Deep Genomics, Enlitic, twoXAR, and Insilico Medicine
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global AI in biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation-

• By Component
  • Software
  • Hardware
  • Services
• By Application
  • Drug Discovery & Development
  • Clinical Trials & Optimization
  • Medical Imaging
  • Diagnostics
  • Others
• By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutes
  • Healthcare Providers
  • CRO & CDMO
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AstraZeneca
  • Bristol-Myers Squibb
  • Gilead Sciences, Inc.
  • Sanofi
  • Abbott Laboratories
  • Biogen
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Amgen, Inc.
  • Merck KGaA
  • Johnson & Johnson Services, Inc.
  • Hoffmann-La Roche Ltd.
  • Novartis AG
  • Deep Genomics
  • NVIDIA Corporation
  • Verge Genomics
  • Recursion Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Component
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global AI in Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global AI in Biotechnology Market, By Component, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hardware
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global AI in Biotechnology Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Drug Discovery & Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Clinical Trials & Optimization
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Medical Imaging
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global AI in Biotechnology Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Biotechnology Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Healthcare Providers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• CRO & CDMO
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global AI in Biotechnology Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bristol-Myers Squibb
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Gilead Sciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
  • Biogen
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Amgen, Inc.
  • Merck KGaA
  • Johnson & Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Deep Genomics
  • NVIDIA Corporation
  • Verge Genomics
  • Recursion Pharmaceuticals

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact